Conclusion: Disclosure of interest: All authors: nothing to disclose E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P2131 - ESOC25-2296 MANAGEMENT OF TIA AND STROKE ATTACK RISK STRATIFICATION: EXPERIENCE IN AN ALGERIAN PERIPHERAL HOSPITAL Amina Behiri 1 , Sonia Nouioua 1 , Feroudja Ramdane Cherif 1 1 Department of Neurology El Maham, cherchell, Algeria Background and Aims: The aim of our study is to evaluate the management efficiency for TIA in an Algerian peripheral hospital, and to analyze the risk factors associated with outcome to an ischemic stroke
Instead, Jeaveau is an injectable neuromodulator, which helps reduce wrinkles by decreasing the intensity of repetitive facial expressions
It's frequently referenced alongside MOTS-c and NAD+ in research contexts, given the complementary nature of their respective pathway interactions - particularly how NNMT inhibition influences NAD+ availability in metabolic signalling studies
Trinh, J
10 mg / 3 mL = 3.33 mg/mL 2,500 mcg / 3,333 mcg per mL = 0.75 mL 0.75 mL x 100 = 75 U-100 units Stacking and protocol tracking Recovery protocols often pair TB-500 with BPC-157 on overlapping schedules
